Volume proceeds price, and we had low volume day , went up $6 share and 20% float is short!
TIK TOK, see you all north of $50 next week as SHORTS MUST COVER, and PAY DIVIDEND if they don’t cover!
VOLUME comes in, this stock $MEDS will make $HALO look like a walk in the park!
$MEDS also has only 1/4 of the float as $HALO did , and with 20% float short, coupled with FLOAT LOCK, and $8 per share dividend coming MOTHER OF ALL SHORT SQUEEZES is inbound in my humble opinion!
$MEDS on supersonic speed as you can see the FLOAT LOCK with a $1 spread between bid and ask!
Premarket Monday and everyday next week will be SPECTACULAR in my opinion based on the above!
Management set “LONGS” up to be KINGS here and one of the MOST REPUTABLE law firms handled this transaction!
A+
Have super weekend friends and the smell in here is “shorts about to be fried” “deep fried” next week when this $MEDS pulls a SUPERSONIC $HOLO move on 1/4 of the float that $HOLO had!
$8 DIVIDEND COMING !
20% of a 830,000 float SHORTED
FLOAT LOCK
EVERYONE WILL be jumping in to get that dividend and PERFECT ROCKET right here folks will remember..
MEDS $MEDS
ALL my humble opinion, and not financial advise!
Short fry coming next week as shorts MUST COVER, plain, pure , simple!
Respectfully,
Maverick
Recent MEDS News
- TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K • GlobeNewswire Inc. • 04/23/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 01:30:31 PM
- TRxADE Health, Inc. Announces Special Cash Dividend • GlobeNewswire Inc. • 03/06/2024 01:05:00 PM
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 02/26/2024 05:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:05:42 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:50:57 PM
- Trxade health, Inc files its 3Q 10Q • GlobeNewswire Inc. • 01/17/2024 02:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 02:05:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 11:12:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 10:25:42 PM
- TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q. • GlobeNewswire Inc. • 11/29/2023 11:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 05:29:14 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 06:51:30 PM
- TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023. • GlobeNewswire Inc. • 10/17/2023 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 05:25:16 PM
- Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales • GlobeNewswire Inc. • 10/12/2023 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:05:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 01:29:09 PM
- Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry. • GlobeNewswire Inc. • 10/04/2023 12:05:00 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 09/25/2023 12:06:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 09:28:31 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 09/08/2023 02:42:39 PM
- Superlatus Announces Planned Expansion into Pet Food Market • GlobeNewswire Inc. • 09/07/2023 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 10:15:36 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM